
Wavemaker Partners
182 Cecil Street, #17-01, Frasers Tower, Singapore, 069547
Overview
Wavemaker Group is a multi-faceted cross border venture capital firm founded in 2003. The firm is dual headquartered in Los Angeles and Singapore and has raised over $580M across multiple funds. We currently have a team of 70 people across both sides of our practice. Wavemaker is one of the most active early-stage investors in Southern California and Southeast Asia and has invested in over 360 companies in the last 17 years.
- Total investments
- 159
- Lead investments
- 62
- Investments · 12mo
- 10
- Active investors
- 3
Sector focus
- AgTech
- Business Intelligence
- Enterprise Software
- Financial Services
- FinTech
- Marketing Automation
- Mobile
- Robotics
Investment portfolio
- Neocrete
Led · Equity · Aug 2026
Neocrete develops additives that allow low-quality fly ash and volcanic ash to replace 30%–50% of cement in concrete while maintaining strength, durability, and workability. Founded in 2018 in New Zealand, the company positions its technology as both lower-carbon and lower-cost compared with conventional cement. Its technology is commercially deployed in Southeast Asia, including Readymix Brunei, which has poured 3,700 cubic metres of Neocrete concrete and achieved a 25% reduction in embodied carbon, avoiding about 215 tonnes of CO2 and saving nearly $20,000. The company expects a much larger deployment at Brunei’s Muara Port redevelopment, projected to use ~65,000 cubic metres of Neocrete concrete, save about $300,000 and avoid roughly 5,200 tonnes of CO2. With the recent $3.5M raise, Neocrete plans to expand into European and U.S. markets and scale further commercial deployments.
- pQCee
Participated · Seed · Jul 2026
pQCee develops practical and interoperable post-quantum cryptographic software aimed at protecting enterprise data from future quantum threats. The company emphasizes solutions that help organizations comply with emerging global security regulations. Headquartered and founded in Singapore, pQCee focuses on defending against harvest-now-decrypt-later attacks. Financially, it has just completed a $3.9 million seed round — its second institutional financing. pQCee plans to use the new funding to grow its Singapore workforce and expand its market reach across Asia, with accelerated entry plans for the U.S., Europe, and the Middle East.
- Confluxe
Led · Seed · Jul 2026
Launched in March by Louis Coucke and Rajesh Narkar, Confluxe aims to introduce international premium apparel labels to India using an asset-light model that handles sourcing, merchandising, marketing, technology and retail expansion while letting brands retain visibility over their business. The company debuted Brazilian menswear label Urban Performance with price points between ₹3,999 and ₹20,000 and plans a September launch of a US-based premium denim brand that is part of a global apparel group generating more than $3 billion in annual revenue. Confluxe targets brands priced above ₹3,500 across menswear, womenswear and outdoor categories and expects each brand to reach about ₹100 crore in annual revenue within three years. It plans to build brands online first and then expand into shop-in-shop formats and exclusive stores, and is pursuing both established global brands and emerging labels. The founders are targeting a ₹500–1,000 crore business within three to five years and say the funnel of brands wanting to enter India has grown since their funding announcement. The company is positioning itself between fast fashion and luxury, seeking consumers willing to pay more for quality and differentiated products rather than logo-led luxury.
- ChemT Biotechnology
Led · Seed · Jun 2026
ChemT Biotechnology builds an AI-driven Virtual Cell platform called CelMo, trained on billions to trillions of proprietary sequencing reads and validated in the lab to simulate how cells respond to manufacturing conditions, genetic changes, and stresses. Using CelMo, ChemT identifies target cell pathways, designs small molecules to modulate cell behavior, and supports cell engineering to improve manufacturing performance. The company reports CelMo has delivered a 50% increase in antibody output and a 40% reduction in production timelines in CHO cells. Its flagship small-molecule product Chemplify for T-cell manufacturing has demonstrated 50% faster development, 3× scalability, 60% lower costs, and 10× higher cell expansion yield. ChemT says it has established commercial partnerships with more than 40 pharmaceutical, biotech, and CDMO customers globally. The company plans to expand CelMo beyond CHO and T cells into stem cells, NK cells, and HEK cells while advancing products toward GMP and regulatory readiness.
- DataMasque
Led · Series A · Jun 2026
DataMasque provides a platform that creates synthetically identical customer data by masking personally identifiable information while preserving relationships and values within datasets. The company says its approach maintains data consistency across systems to avoid breaking analytics when data is de-identified in different clouds. It has added capabilities to de-identify unstructured data, including call transcripts, emails and logs, to broaden usable enterprise information for AI and analytics. DataMasque reported six-fold ARR growth and a tripling of headcount since its 2023 $2.3 million seed round, and more than 95% of its revenue now comes from production deployments. The startup is pursuing expansion into key markets including Australia and plans to enhance its platform for regulated sectors such as financial services, telecommunications and government. It also cited a Strategic Collaboration Agreement with AWS as part of its ecosystem positioning.